The only way from here is up.
Sales in this business are easily $700M p.a. at worst. It should be valued at 2 x sales at the very least.
Current valued at a 4% PAT margin. It could easily achieve a 10-20% PAT margin over time. 2.5 to 5 times upside in time is the minimum upside from here and shorters can enjoy the pain of covering when the next big boy enters the register.
I hope shorters upped their assault today as the pain only multiplies when the buyers enter. They will gradually drive the price up and leave shorters in their wake.
- Forums
- ASX - By Stock
- Ann: May 2021 Business Update
The only way from here is up.Sales in this business are easily...
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KGN (ASX) to my watchlist
|
|||||
Last
$4.56 |
Change
0.045(1.00%) |
Mkt cap ! $453.7M |
Open | High | Low | Value | Volume |
$4.52 | $4.59 | $4.49 | $260.5K | 57.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 2958 | $4.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.56 | 2358 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 620 | 4.560 |
10 | 4489 | 4.550 |
16 | 9759 | 4.540 |
12 | 8959 | 4.530 |
13 | 24769 | 4.520 |
Price($) | Vol. | No. |
---|---|---|
4.570 | 7823 | 21 |
4.580 | 8362 | 14 |
4.590 | 17390 | 16 |
4.600 | 16963 | 13 |
4.610 | 9483 | 11 |
Last trade - 10.39am 16/07/2024 (20 minute delay) ? |
Featured News
KGN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online